Counsel for a bodog poker review pharmaceutical company retained Cornerstone Research to assess the company’s incentives to launch a bodog poker review drug while ongoing patent litigation remained unresolved.
Counsel for a bodog poker review pharmaceutical company retained Cornerstone Research to assess the company’s incentives to launch a bodog poker review drug while ongoing patent litigation remained unresolved. The plaintiffs alleged that the bodog poker review pharmaceutical company had conspired with its co-defendant, a branded pharmaceutical company, to monopolize the market for the drug by entering into an agreement in which the branded company paid the bodog poker review company to delay the launch of the bodog poker review product until the patent litigation had ended.
The expert concluded that the agreement did not delay bodog poker review entry.
Cornerstone Research worked with an economics expert to compare the potential patent infringement damages faced by the bodog poker review company if it launched the bodog poker review product prior to the resolution of the patent litigation to the additional profits the bodog poker review company would have earned from entering early. The analysis demonstrated that the risks faced by the bodog poker review company from launching the bodog poker review product prior to the resolution of the patent litigation outweighed the potential benefits. The expert concluded that the agreement did not delay bodog poker review entry.